{"title":"Clinical Effect Analysis of Atorvastatin Calcium Combined with Ezetimibe Tablets in the Treatment of Coronary Heart Disease","authors":"Xintian Wang","doi":"10.26689/cr.v1i2.5228","DOIUrl":"https://doi.org/10.26689/cr.v1i2.5228","url":null,"abstract":"Objective: To explore the effective drug treatment plan for patients with coronary heart disease. Methods: A total of 59 patients with coronary heart disease were recruited and divided into the study group (30 cases, treated with atorvastatin calcium combined with ezetimibe tablets) and the control group (29 cases, treated with atorvastatin) after drawing lots, and the therapeutic effects of the two groups were compared. Results: After treatment, the blood lipid level, cardiac function, inflammatory factor level, and clinical effective rate of the study group were better than those of the control group (P < 0.05); there was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion: The clinical effect of atorvastatin calcium combined with ezetimibe tablets in the treatment of patients with coronary heart disease is significant, and it has the value of promotion and application.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of Efficacy and Safety Between Video- Assisted Thoracoscopic Surgery and Traditional Thoracotomy in the Treatment of Esophageal Cancer","authors":"Fubing Sun","doi":"10.26689/cr.v1i2.5246","DOIUrl":"https://doi.org/10.26689/cr.v1i2.5246","url":null,"abstract":"Objective: To compare the therapeutic effect of video-assisted thoracoscopic surgery and traditional thoracotomy in patients with esophageal cancer. Methods: 60 patients with esophageal cancer who were treated from February 2022 to February 2023 were randomly divided into groups. Video-assisted thoracoscopic surgery was included in group A, and thoracotomy was included in group B. The curative effects of esophageal cancer surgery were compared. Results: All surgical indexes in group A were better than those in group B (P < 0.05); interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-alpha) levels in group A were lower than those in group B (P < 0.05); the postoperative SF-36 score in group A was higher than that in group B (P < 0.05); the postoperative complication rate in group A was lower than that in group B (P < 0.05). Conclusion: Video-assisted thoracoscopic treatment for patients with esophageal cancer can reduce postoperative inflammatory response and reduce surgical trauma, which is safe and efficient.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Study on the Application Value of Amlodipine Combined with Enalapril in the Treatment of Elderly Hypertension","authors":"Ling Yang","doi":"10.26689/cr.v1i2.5200","DOIUrl":"https://doi.org/10.26689/cr.v1i2.5200","url":null,"abstract":"Objective: To explore the application value of amlodipine combined with enalapril in the treatment of elderly hypertension. Methods: A total of 600 hypertensive patients admitted between May 2020–2023 were recruited and divided into the study group and the control group, with 300 cases in each group, using a double-blind mechanism. The study group was treated with enalapril and amlodipine, while the control group was treated with enalapril. The changes in vascular endothelium, blood pressure performance, pulse pressure level, and drug side effects were compared between the groups. Results: Before treatment, the changes in vascular endothelium showed no significant difference between the groups (P > 0.05); after treatment, the changes in the study group were significantly better than the control group (P < 0.05). Before treatment, the performance of systolic and diastolic blood pressures in the two groups showed no significant difference (P > 0.05); after treatment, the performance in the study group was lower than that in the control group (P < 0.05). Before treatment, the pulse pressure levels of the two groups showed no significant difference (P > 0.05); after treatment, the pulse pressure levels of the study group were significantly better than that of the control group (P < 0.05). The side effects of medication in the study group were significantly lower than those in the control group (P < 0.05). Conclusion: Amlodipine combined with enalapril has a higher curative effect in the treatment of elderly hypertension, which is worthy of promotion.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy and Safety of Percutaneous Closure in Patients with Patent Foramen Ovale and Migraine","authors":"Guanghua Yan","doi":"10.26689/cr.v1i2.5294","DOIUrl":"https://doi.org/10.26689/cr.v1i2.5294","url":null,"abstract":"Objective: To analyze the therapeutic effect of percutaneous closure of patent foramen ovale (PFO) and migraine. Methods: A total of 150 patients with PFO and migraine who were admitted to the hospital from January 2021 to May 2023 were recruited and divided into groups by random number table, the study group took percutaneous closure and drug treatment, and the control group took conventional drug treatment. The treatment effects between the groups were compared. Results: The total effective rate of the study group was higher than that of the control group (P < 0.05). Before treatment, there was no difference in migraine quantitative evaluation indicators between the groups (P > 0.05). After treatment, the migraine quantitative evaluation indicators in the study group were better than those in the control group (P < 0.05). The complication rate of the study group was lower than that of the control group (P < 0.05). Followed up for 1 to 3 months, the recurrence rate of the study group was lower than that of the control group (P < 0.05). Conclusion: Percutaneous closure for patients with PFO and migraine can improve the symptoms of migraine, enhance the curative effect, and have fewer postoperative complications.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135864070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Study on Left Atrial Function in Patients with Early Left Ventricular Remodeling in Essential Hypertension Based on Two-Dimensional Speckle Tracking Technology","authors":"Lingling Wang, Jing Dong, Wenfang Wu, Pingyang Zhang","doi":"10.26689/cr.v1i2.5349","DOIUrl":"https://doi.org/10.26689/cr.v1i2.5349","url":null,"abstract":"Objective: To use two-dimensional speckle tracking imaging (2D-STI) to analyze the functional changes of the left atrium before hypertrophic changes in the left ventricular configuration in the early stage of hypertension and to explore the clinical value of this technology in evaluating the changes of left atrial characteristics in patients with hypertension. Methods: 70 cases of patients with essential hypertension who met the requirements of this study after clinical diagnosis and routine ultrasound examination were recruited and divided into two groups according to the Ganan method: 38 cases in the left ventricular standard remodeling group, 32 cases in the left ventricular concentric remodeling group, and 40 healthy people with matched age and sex were randomly selected as the control group. The mean peak strains and strain rates of the left atrial systole, early diastole, and late diastole of each group were obtained using 2D-STI. The above parameters and indicators were used for comparative analysis. Results: Compared with the healthy control group, the values of peak strains and strain rates during early diastole were statistically different in both remodeling groups; compared with the standard remodeling group, the values of peak strains and strain rates in all periods were significantly different in the concentric remodeling group (P < 0.05). Conclusion: 2D-STI can be more sensitive and convenient to reflect the characteristic changes of left atrial myocardium in patients with early essential hypertension.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135864489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New Progress of Clinical Application of Nicorandil in the Treatment of Coronary Heart Disease","authors":"Lingbo Wang, Chengguo Wang","doi":"10.26689/cr.v1i1.5057","DOIUrl":"https://doi.org/10.26689/cr.v1i1.5057","url":null,"abstract":"Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85996463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Yesil, Hakan Uyar, Özcan Örsçelik, B. Özkan, A. Çelik, İsmail Türkay Özcan, Mehmet Necdet Akkuş
{"title":"Comparison of the Effect of Clopidogrel and Ticagrelor on the Development of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction","authors":"E. Yesil, Hakan Uyar, Özcan Örsçelik, B. Özkan, A. Çelik, İsmail Türkay Özcan, Mehmet Necdet Akkuş","doi":"10.26689/cr.v1i1.4965","DOIUrl":"https://doi.org/10.26689/cr.v1i1.4965","url":null,"abstract":"Background: No-reflow phenomenon (NRP) is one of the most important factors affecting myocardial reperfusion. Objective: In this study, we investigated the effect of ticagrelor and clopidogrel on the development of NRP in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI). Methods: Our single-center, retrospective study included 200 patients with AMI who underwent PCI. The patients were divided into two groups according to the antiplatelet regimen given before PCI: clopidogrel- and ticagrelor-loaded groups. NRP was defined based on TIMI flow classification or post-procedural ST segment resolution. The difference in the parameters between patients with no-reflow and patients with normal flow as well as the effect of ticagrelor and clopidogrel on NRP were evaluated. Results: There was no difference in baseline characteristics between patients with no-reflow and patients with normal flow. The number of patients with ST-elevation myocardial infarction was higher in the ticagrelor-loaded group compared with the clopidogrel-loaded group (P = 0.013). Age, aspartate aminotransferase (AST), C-reactive protein (CRP), peak creatine kinase MB (CK-MB), diabetes mellitus (DM) rate, length of stent, number of stents, and number of patients with low ejection fraction were significantly higher in the no-reflow group compared with the normal flow group. The rate of NRP development was significantly lower in ticagrelor-loaded patients (19% P = 0.001), independent of other independent variables, including age, DM, AST, CRP level, number of stents implanted, and type of myocardial infarction (odds ratio = 0.228, 95% confidence interval = 0.102–0.512, P < 0.001). Conclusion: Ticagrelor is superior to clopidogrel in preventing the development of NRP.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87157463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julieta Lozita, Judith Mailén Vicentín, María Florencia Melgarejo Otarola, Jorge Andrés Paolasso, Roberto Miguel Ángel Colque, P. Sarmiento
{"title":"Dilated Cardiomyopathy in a Patient with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)","authors":"Julieta Lozita, Judith Mailén Vicentín, María Florencia Melgarejo Otarola, Jorge Andrés Paolasso, Roberto Miguel Ángel Colque, P. Sarmiento","doi":"10.26689/cr.v1i1.4964","DOIUrl":"https://doi.org/10.26689/cr.v1i1.4964","url":null,"abstract":"Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare pathology that belongs to a group of diseases characterized by necrotizing vasculitis of small and medium-sized systemic blood vessels. Symptomatic cardiovascular involvement occurs in 27%–47% of cases of EGPA and is one of the most severe manifestations. The diagnosis is usually confirmed by eosinophilic infiltration observed in tissue biopsy, but with the recent inclusion of cardiac magnetic resonance imaging (MRI), the former can be replaced. Early diagnosis is important because timely treatment is often associated with improvement.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79170840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Myllena Lemes Scardino Vieira, Tamires Mota Toni, Claudio Spinola Najas
{"title":"Importance of Cardiac Rehabilitation in Patients with Structural Heart Changes Secondary to Ankylosing Spondylitis: A Case Report","authors":"Myllena Lemes Scardino Vieira, Tamires Mota Toni, Claudio Spinola Najas","doi":"10.26689/cr.v1i1.4963","DOIUrl":"https://doi.org/10.26689/cr.v1i1.4963","url":null,"abstract":"Patients with ankylosing spondylitis (AS) may present with cardiac manifestations, mainly valvular disease and dilation of the aortic root. Rehabilitation programs to improve cardiovascular capacity are important for maintaining the quality of life of these patients, which often deteriorates with disease impairments and dysfunctions when not corrected. We report a case of a 67-year-old man, diagnosed with ankylosing spondylitis 20 years ago with structural cardiac changes. The patient underwent a rehabilitation program that involves stretching, aerobic and resistance exercises, and health education. In order to analyze the patient’s effort during activities of daily living and instrumental activities, we used Borg Rating of Perceived Exertion Scale. With constant rehabilitation, the patient maintained functional capacity in activities of daily living and instrumental activities over the years even with structural heart changes.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74359837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Matsumoto, S. Yasuda, T. Cho, Y. Matsuki, Yoshiyuki Kobayashi, Kaori Mori, K. Uchida
{"title":"A Case of Renal Hemorrhage After Mitral Valvuloplasty for Active Infective Endocarditis with Renal Infarction","authors":"A. Matsumoto, S. Yasuda, T. Cho, Y. Matsuki, Yoshiyuki Kobayashi, Kaori Mori, K. Uchida","doi":"10.26689/cr.v1i1.4962","DOIUrl":"https://doi.org/10.26689/cr.v1i1.4962","url":null,"abstract":"A 55-year-old woman with atopic dermatitis was admitted to the hospital with a diagnosis of septic shock. She had multiple cerebral and left renal infarctions. Transesophageal echocardiography revealed a 10 mm mobile verrucous lesion at the mitral valve. Emergency mitral valvuloplasty was performed, and the verrucous lesion was successfully removed. The patient was hemodynamically stable and was admitted to the postoperative intensive care unit (ICU) under ventilatory support. On postoperative day 3, anemia progressed, and on postoperative day 4, the patient went into shock. Emergency embolization was performed for hemostasis, and the patient’s circulation improved. This is the first report of a case of renal hemorrhage after surgery for infective endocarditis. This case is valuable for the treatment of this disease in which various complications occur.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"151 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79554796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}